|
|
| Catalog Number |
PDPB740D |
| Medical Device Problem Code |
Material Separation (1562)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/26/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that a patient underwent an unknown procedure on (b)(6)2024 and suture was used.During the procedure, it was reported by a sales rep that during wound closure for abdominal fascia, the needle had been detached in the middle of the handling of a needle.The caulking must be weak.It was a control release needle.Lot number - tmmjqr or ubmczs - unknown if this is the correct lot number.There were no adverse consequences reported.Additional information was requested.
|
| |
|
Additional Manufacturer Narrative
|
|
Product complaint (b)(4).H6 component code: g07002 - device not returned this report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, and the following was obtained via: what is the procedure name?= unk please clarify which is the correct lot number (tmmjqr or ubmczs)?= it could not be determined.Both lots are the possible number.When was the needle detached/pulled off from the suture (in the package, during removal from package, during handling prior to use on patient or during use on the patient)? please specify= during sutuirng please perform and document the follow up attempt for product return.Please document the shipment tracking number in notes or rmao sections.=we regularly contact with sales rep about the device returning.Please provide the source or name and title of external person providing answers to follow-up (external person submitting answers to sales rep or loc/bq)= (b)(6).D4: full udi currently unavailable since the exact lot of the suspected device cannot be determined.Possible lots: tmmjqr and ubmczs.
|
| |
|
Additional Manufacturer Narrative
|
|
Product complaint # (b)(4).Date sent to the fda: 9/18/2024.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H6 component code: g07002 no device problem found.The actual device batch number associated with this event is not known.The possible batch numbers are reported as follows: batch: ubmczs; batch: tmmjqr.A manufacturing record evaluation was performed for the finished device ubmczs / pdpb740 batch number, and no non-conformances were identified.Expiration date: jan/31/2026.Date of mfg.: feb/07/2024.D4: udi: (b)(4).A manufacturing record evaluation was performed for the finished device tmmjqr / pdpb740 batch number, and no non-conformances were identified.Expiration date: oct/31/2025.Date of mfg.: nov/16/2023.D4: udi: (b)(4).H3 investigational summary: the product was returned to ethicon for evaluation.One winding former with two unused strands was received for analysis.Product code is pdpb740d which is a control release and requires eight strands per packet.In order to evaluate the conditions of the returned sample, the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strands no anomalies or pull off was observed during the evaluation.The product code pdpb740d contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined.As per the condition of the returned sample, the functional test could not be performed.It should be noted that as part of our quality process, each batch is randomly inspected and functionally tested during manufacturing to ensure the device meets the required specifications prior to shipment.
|
| |
|
Search Alerts/Recalls
|
|
|